Turner, S J <br/><br/>
Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.  [electronic resource] 

 -  Mycoses  Aug 2014 
 - 489-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-0507 
<br/><br/><label>Standard No.: </label>10.1111/myc.12187  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antifungal Agents--therapeutic use<br/>Caspofungin<br/>Cost-Benefit Analysis<br/>Echinocandins--therapeutic use<br/>Health Care Costs<br/>Humans<br/>Lipopeptides<br/>Mycoses--drug therapy<br/>Treatment Failure<br/>Treatment Outcome<br/>Turkey<br/>Voriconazole--therapeutic use